Sykes Dominic L, Morice Alyn H
Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
Hull York Medical School, University of York, York, United Kingdom.
Front Physiol. 2021 Jun 29;12:684080. doi: 10.3389/fphys.2021.684080. eCollection 2021.
In clinical practice, we commonly face adversity when encountering dysfunction of the cough reflex. Similar to ancient Roman deity Janus, it often presents with one of two opposing "faces". Continual aberrant activation of the cough reflex, also known as chronic cough, can cause great detriment to quality of life and many of these patients are left misdiagnosed and undertreated. In contrast, loss of normal functioning of the cough reflex is the cause of a significant proportion of mortality in the elderly, primarily through the development of aspiration pneumonia. In this review we discuss both hyper- and hypo-activation of the cough reflex and how airway reflux and chronic aspiration may be involved in the aetiology and sequalae of both disease states. We detail the physiological and pharmacological mechanisms involved in cough, and how the recent development of P2X3 receptor antagonists may lead to the first pharmaceutical agent licensed for chronic cough. The treatment and prevention of loss of the cough reflex, which has been largely neglected, is also discussed as novel low-cost interventions could help prevent a number of hospital and domiciliary deaths from both acute and chronic aspiration.
在临床实践中,当遇到咳嗽反射功能障碍时,我们常常面临困境。与古罗马神祇杰纳斯相似,它常常呈现出两个相反的“面孔”之一。咳嗽反射的持续异常激活,也就是所谓的慢性咳嗽,会对生活质量造成极大损害,而且许多这类患者被误诊且治疗不足。相反,咳嗽反射正常功能的丧失是导致老年人相当一部分死亡的原因,主要是通过吸入性肺炎的发展。在这篇综述中,我们讨论了咳嗽反射的过度激活和激活不足,以及气道反流和慢性误吸如何可能参与这两种疾病状态的病因和后遗症。我们详细阐述了咳嗽所涉及的生理和药理机制,以及P2X3受体拮抗剂的最新进展如何可能导致首个获批用于治疗慢性咳嗽的药物。咳嗽反射丧失的治疗和预防在很大程度上被忽视了,本文也对此进行了讨论,因为新型低成本干预措施有助于预防因急性和慢性误吸导致的许多医院和家庭死亡。